Concepedia

Michael H. Silverman

MH

Statistics

Publications

37

Citations

2K

H-Index

22

Active since

1990

Affiliations

Can-Fite BioPharma (Israel)(Current)

Dana-Farber Cancer Institute

Rabin Medical Center

The University of Texas MD Anderson Cancer Center

National Institute of Emergency Medicine "Pirogov"

Michael H. Silverman is an author at Can-Fite BioPharma (Israel) specializing in medicine, pharmacology, and pharmacotherapy.

Publications per year

1990–2024

37

Publications

37

Safety and Efficacy of TG101348, a Selective JAK2 Inhibitor, in Myelofibrosis

Animesh Pardanani, Jason Gotlib, Catriona Jamieson et al. · Journal of Clinical Oncology · 2011 · 397 citations · Full text

Medicine, Hematology, Pharmacology +17

ZYC101a for Treatment of High-Grade Cervical Intraepithelial Neoplasia

Francisco García, Karl Ulrich Petry, Laila I. Muderspach et al. · Obstetrics and Gynecology · 2004 · 188 citations

Medicine, Oncology, Pharmacotherapy +17

Clinical evidence for utilization of the A3 adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trial.

Michael H. Silverman, Vibeke Strand, Doron Markovits et al. · PubMed · 2008 · 132 citations

Medicine, Pharmacology, Pharmacotherapy +17

Modulating BET Bromodomain Inhibitor ZEN‐3694 and Enzalutamide Combination Dosing in a Metastatic Prostate Cancer Patient Using CURATE.AI, an Artificial Intelligence Platform

Allan J. Pantuck, Dong‐Keun Lee, Theodore Kee et al. · Advanced Therapeutics · 2018 · 127 citations

Medicine, Oncology, Pharmacology +17

Pilot Trial of Cyclosporine 1% Ophthalmic Ointment in the Treatment of Keratoconjunctivitis Sicca

Robert Laibovitz, Suzanne Solch, Kim Andriano et al. · Cornea · 1993 · 111 citations

Medicine, Dermatology, Pharmacology +13

1–5 of 37